||Recombinant Rat Igf1 (Accession # AAA41386) was produced in E. coli-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. Karey, K.P. et al. (1988) Cancer Research 48:4083.The ED50 for this effect is typically 0.6 - 3 ng/mL.
||Recombinant Rat Igf1 has a calculated MW of 8.8 kDa.
||>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).